Form 8-K - Current report:
SEC Accession No. 0001387131-20-004919
Filing Date
2020-05-15
Accepted
2020-05-15 16:50:39
Documents
13
Period of Report
2020-05-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_051520.htm 8-K 31179
2 PRESENTATION BY THE COMPANY ex99-01.htm EX-99.01 18136
3 GRAPHIC ex9901_001.jpg GRAPHIC 73105
4 GRAPHIC ex9901_002.jpg GRAPHIC 286206
5 GRAPHIC ex9901_003.jpg GRAPHIC 101375
6 GRAPHIC ex9901_004.jpg GRAPHIC 210842
7 GRAPHIC ex9901_005.jpg GRAPHIC 167399
8 GRAPHIC ex9901_006.jpg GRAPHIC 217898
9 GRAPHIC ex9901_007.jpg GRAPHIC 182614
10 GRAPHIC ex9901_008.jpg GRAPHIC 196389
11 GRAPHIC ex9901_009.jpg GRAPHIC 233321
12 GRAPHIC ex9901_010.jpg GRAPHIC 177373
13 GRAPHIC ex9901_011.jpg GRAPHIC 54676
  Complete submission text file 0001387131-20-004919.txt   2670385
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 20886308
SIC: 2834 Pharmaceutical Preparations